Effects of glucocorticoids on gene transcription

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 51-62

  Hayashi, Ryuji ^a   Wada, Hiroo ^a   Ito, Kazuhiro ^a   Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Glucocorticoid resistance; Histone acetylation deacetylation; Nuclear factor B

Indexed keywords

ANTIINFLAMMATORY AGENT; DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LONG ACTING DRUG; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR;

ACETYLATION; ALLERGIC DISEASE; ASTHMA; CYTOPLASM; DISSOCIATION; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG BINDING; DRUG EFFECT; ENZYME REPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENOMICS; HISTORY OF MEDICINE; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN TARGETING; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHROMATIN ASSEMBLY AND DISASSEMBLY; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; NF-KAPPA B; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION, GENETIC;

EID: 4644263340     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.011     Document Type: Review

References (84)

1. I.M. Adcock, Y. Nasuhara, D.A. Stevens, and P.J. Barnes Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement Br. J. Pharmacol. 127 1999 1003 1011
2. I.M. Adcock, K. Maneechotesuwan, and O. Usmani Molecular interactions between glucocorticoids and long-acting beta2-agonists J. Allergy Clin. Immunol. 110 2002 S261 S268
3. V.G. Allfrey, R. Faulkner, and A.E. Mirsky Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis Proc. Natl. Acad. Sci. U. S. A. 51 1964 786 794
4. B.P. Ashburner, S.D. Westerheide, and A.S.J. Baldwin The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol. Cell. Biol. 21 2001 7065 7077
5. A.S. Baldwin Jr. Series introduction: the transcription factor NF-kappaB and human disease J. Clin. Invest. 107 2001 3 6
6. N.A. Barlev, L. Liu, N.H. Chehab, K. Mansfield, K.G. Harris, T.D. Halazonetis, and S.L. Berger Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol. Cell 8 2001 1243 1254
7. P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids Eur. Respir. J. 19 2002 182 191
8. P.J. Barnes, and I.M. Adcock Transcription factors and asthma Eur. Respir. J. 12 1998 221 234
9. P.J. Barnes, and M. Karin Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N. Engl. J. Med. 336 1997 1066 1071
10. P.J. Barnes, K.F. Chung, and C.P. Page Inflammatory mediators of asthma: an update Pharmacol. Rev. 50 1998 515 596
11. S. Belikov, B. Gelius, and O. Wrange Hormone-induced nucleosome positioning in the MMTV promoter is reversible EMBO J. 20 2001 2802 2811
12. R.K. Bledsoe, V.G. Montana, T.B. Stanley, C.J. Delves, C.J. Apolito, D.D. McKee, T.G. Consler, D.J. Parks, E.L. Stewart, T.M. Willson, M.H. Lambert, J.T. Moore, K.H. Pearce, and H.E. Xu Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 2002 93 105
13. J. Boyes, P. Byfield, Y. Nakatani, and V. Ogryzko Regulation of activity of the transcription factor GATA-1 by acetylation Nature 396 1998 594 598
14. H. Braun, R. Koop, A. Ertmer, S. Nacht, and G. Suske Transcription factor Sp3 is regulated by acetylation Nucleic Acids Res. 29 2001 4994 5000
15. C. Caelles, J.M. Gonzalez-Sancho, and A. Munoz Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway Genes Dev. 11 1997 3351 3364
16. Y.Z. Chen, and J. Qiu Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid Molec. Cell Biol. Res. Commun. 2 1999 145 149
17. L. Chen, W. Fischle, E. Verdin, and W.C. Greene Duration of nuclear NF-kappaB action regulated by reversible acetylation Science 293 2001 1653 1657
18. J.D. Croxtall, Q. Choudhury, and R.J. Flower Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism Br. J. Pharmacol. 130 2000 289 298
19. J.D. Croxtall, P.T. Van Hal, Q. Choudhury, D.W. Gilroy, and R.J. Flower Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells Br. J. Pharmacol. 135 2002 511 519
20. K. De Bosscher, W. Vanden Berghe, L. Vermeulen, S. Plaisance, E. Boone, and G. Haegeman Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell Proc. Natl. Acad. Sci. U. S. A. 97 2000 3919 3924
21. P. Demoly, N. Basset-Seguin, P. Chanez, A.M. Campbell, C. Gauthier-Rouviere, P. Godard, F.B. Michel, and J. Bousquet c-fos proto-oncogene expression in bronchial biopsies of asthmatics Am. J. Respir. Cell Mol. Biol. 7 1992 128 133
22. P. Demoly, P. Chanez, J.L. Pujol, R.C. Gauthier, F.B. Michel, P. Godard, and J. Bousquet Fos immunoreactivity assessment on human normal and pathological bronchial biopsies Respir. Med. 89 1995 329 335
23. A.J. De Ruijter, A.H. Van Gennip, H.N. Caron, S. Kemp, and A.B. Van Kuilenburg Histone deacetylases (HDACs): characterization of the classical HDAC family Biochem. J. 370 2003 737 749
24. C.E. Donovan, D.A. Mark, H.Z. He, H.C. Liou, L. Kobzik, Y. Wang, G.T. De Sanctis, D.L. Perkins, and P.W. Finn NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation J. Immunol. 163 1999 6827 6833
25. O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.H. Block Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells J. Biol. Chem. 274 1999 1005 1010
26. O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.H. Block Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells J. Biol. Chem. 274 1999 1005 1010
27. S.J. Evans, T.F. Murray, and F.L. Moore Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain J. Steroid Biochem. Mol. Biol. 72 2000 209 221
28. W. Fischle, V. Kiermer, F. Dequiedt, and E. Verdin The emerging role of class II histone deacetylases Biochem. Cell. Biol. 79 2001 337 348
29. T.M. Fletcher, B.W. Ryu, C.T. Baumann, B.S. Warren, G. Fragoso, S. John, and G.L. Hager Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition Mol. Cell. Biol. 20 2000 6466 6475
30. W. Gu, and R.G. Roeder Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 1997 595 606
31. L.A. Hart, V.L. Krishnan, I.M. Adcock, P.J. Barnes, and K.F. Chung Activation and localization of transcription factor, nuclear factor-kappaB, in asthma Am. J. Respir. Crit. Care Med. 158 1998 1585 1592
32. N. Hirasawa, Y. Sato, Y. Fujita, S. Mue, and K. Ohuchi Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells J. Immunol. 161 1998 4939 4943
33. Z.Q. Huang, J. Li, L.M. Sachs, P.A. Cole, and J. Wong A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription EMBO J. 22 2003 2146 2155
34. K. Ito, P.J. Barnes, and I.M. Adcock Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12 Mol. Cell. Biol. 20 2000 6891 6903
35. K. Ito, S. Lim, G. Caramori, B. Cosio, K.F. Chung, I.M. Adcock, and P.J. Barnes A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression Proc. Natl. Acad. Sci. U. S. A. 99 2002 8921 8926
36. R. Janknecht, and T. Hunter Versatile molecular glue. Transcriptional control Curr. Biol. 6 1996 951 954
37. B.D. Jenkins, C.B. Pullen, and B.D. Darimont Novel glucocorticoid receptor coactivator effector mechanisms Trends Endocrinol. Metab. 12 2001 122 126
38. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
39. I. Jibiki, S. Hashimoto, S. Maruoka, Y. Gon, A. Matsuzawa, H. Nishitoh, H. Ichijo, and T. Horie Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells Am. J. Respir. Crit. Care Med. 167 2003 856 861
40. M. Johnson Effects of beta2-agonists on resident and infiltrating inflammatory cells J. Allergy Clin. Immunol. 110 2002 S282 S290
41. M. Kagoshima, T. Wilcke, K. Ito, L. Tsaprouni, P.J. Barnes, N. Punchard, and I.M. Adcock Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation Eur. J. Pharmacol. 429 2001 327 334
42. M. Karin New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93 1998 487 490
43. O. Kassel, A. Sancono, J. Kratzschmar, B. Kreft, M. Stassen, and A.C. Cato Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 EMBO J. 20 2001 7108 7116
44. M.S. Kim, H.J. Kwon, Y.M. Lee, J.H. Baek, J.E. Jang, S.W. Lee, E.J. Moon, H.S. Kim, S.K. Lee, H.Y. Chung, C.W. Kim, and K.W. Kim Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes Nat. Med. 7 2001 437 443
45. S.J. Lane, I.M. Adcock, D. Richards, C. Hawrylowicz, P.J. Barnes, and T.H. Lee Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes J. Clin. Invest. 102 1998 2156 2164
46. M. Lasa, M. Brook, J. Saklatvala, and A.R. Clark Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38 Mol. Cell. Biol. 21 2001 771 780
47. M. Lasa, S.M. Abraham, C. Boucheron, J. Saklatvala, and A.R. Clark Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38 Mol. Cell. Biol. 22 2002 7802 7811
48. X. Li, J. Wong, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification Mol. Cell. Biol. 23 2003 3763 3773
49. K. Maneechotesuwan, O. Usmani, I.M. Adcock, and P.J. Barnes The modulation of GATA-3 nuclear localization by fluticasone and salmeterol Am. J. Respir. Crit. Care Med. 165 2002 A616 (Abstr)
50. G. Marzio, C. Wagener, M.I. Gutierrez, P. Cartwright, K. Helin, and M. Giacca E2F family members are differentially regulated by reversible acetylation J. Biol. Chem. 2000 10887 10892
51. J.G. McNally, W.G. Muller, D. Walker, R. Wolford, and G.L. Hager The glucocorticoid receptor: rapid exchange with regulatory sites in living cells Science 287 2000 1262 1265
52. E.S. Mendes, A. Pereira, I. Danta, R.C. Duncan, and A. Wanner Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids Eur. Respir. J. 21 2003 989 993
53. A.R. Nair, L.J. Boersma, L. Schiltz, M.A. Chaudhry, R.J. Muschel, and A. Chaudry Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA Cancer Lett. 166 2001 55 64
54. Y. Nasuhara, I.M. Adcock, M. Catley, P.J. Barnes, and R. Newton Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription J. Biol. Chem. 274 1999 19965 19972
55. H.S. Nelson, K.R. Chapman, S.D. Pyke, M. Johnson, and J.N. Pritchard Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers J. Allergy Clin. Immunol. 112 2003 29 36
56. R.M. Nissen, and K.R. Yamamoto The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain Genes Dev. 14 2000 2314 2329
57. A.W. Norman, M.T. Mizwicki, and D.P. Norman Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model Nat. Rev., Drug Discov. 3 2004 27 41
58. Y. Ohmori, R.D. Schreiber, and T.A. Hamilton Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB J. Biol. Chem. 272 1997 14899 14907
59. R.A. Panettieri, P.A. Yadvish, A.M. Kelly, N.A. Rubinstein, and M.I. Kotlikoff Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression Am. J. Physiol. 259 1990 L365 L371
60. A. Polesskaya, I. Naguibneva, A. Duquet, E. Bengal, P. Robin, and A. Harel-Bellan Interaction between acetylated MyoD and the bromodomain of CBP and/or p300 Mol. Cell. Biol. 21 2001 5312 5320
61. C.E. Powell, C.S. Watson, and B. Gametchu Immunoaffinity isolation of native membrane glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90 Endocrine 10 1999 271 280
62. H.M. Reichardt, K.H. Kaestner, J. Tuckermann, O. Kretz, O. Wessely, R. Bock, P. Gass, W. Schmid, P. Herrlich, P. Angel, and G. Schutz DNA binding of the glucocorticoid receptor is not essential for survival Cell 93 1998 531 541
63. H.M. Reichardt, J.P. Tuckermann, M. Gottlicher, M. Vujic, F. Weih, P. Angel, P. Herrlich, and G. Schutz Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor EMBO J. 20 2001 7168 7173
64. L.G. Rider, N. Hirasawa, F. Santini, and M.A. Beaven Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells J. Immunol. 157 1996 2374 2380
65. I. Rogatsky, S.K. Logan, and M.J. Garabedian Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase Proc. Natl. Acad. Sci. U. S. A. 95 1998 2050 2055
66. M.G. Rosenfeld, and C.K. Glass Coregulator codes of transcriptional regulation by nuclear receptors J. Biol. Chem. 276 2001 36865 36868
67. S. Saccani, S. Pantano, and G. Natoli Two waves of nuclear factor kappaB recruitment to target promoters J. Exp. Med. 193 2001 1351 1359
68. S. Saccani, S. Pantano, and G. Natoli p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment Nat. Immunol. 3 2002 69 75
69. H. Schacke, W.D. Docke, and K. Asadullah Mechanisms involved in the side effects of glucocorticoids Pharmacol. Ther. 96 2002 23 43
70. H. Schacke, H. Hennekes, A. Schottelius, S. Jaroch, M. Lehmann, N. Schmees, H. Rehwinkel, and K. Asadullah SEGRAs: a novel class of anti-inflammatory compounds Ernst Schering Res. Found. Workshop 2002 357 371
71. H. Schacke, A. Schottelius, W.D. Docke, P. Strehlke, S. Jaroch, N. Schmees, H. Rehwinkel, H. Hennekes, and K. Asadullah Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects Proc. Natl. Acad. Sci. U. S. A. 101 2004 227 232
72. J.L. Swantek, M.H. Cobb, and T.D. Geppert Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK Mol. Cell. Biol. 17 1997 6274 6282
73. X. Tong, L. Yin, and C. Giardina Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition Biochem. Biophys. Res. Commun. 317 2004 463 471
74. F. Turlais, A. Hardcastle, M. Rowlands, Y. Newbatt, A. Bannister, T. Kouzarides, P. Workman, and G.W. Aherne High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate) Anal. Biochem. 298 2001 62 68
75. F.D. Urnov, and A.P. Wolffe Chromatin remodeling and transcriptional activation: the cast (in order of appearance) Oncogene 20 2001 2991 3006
76. O. Usmani, K. Maneechotesuwan, K. Tomita, I.M. Adcock, and P.J. Barnes Glucocorticoid receptor immunolocalisation in sputum cells Am. J. Respir. Crit. Care Med. 163 2001 A230 (Abstr)
77. O. Usmani, K. Maneechotesuwan, I.M. Adcock, and P.J. Barnes Glucocorticoid receptor activation following inhaled fluticasone and salmeterol Am. J. Respir. Crit. Care Med. 165 2002 A616 (Abstr)
78. P. Viatour, S. Legrand-Poels, C. Van Lint, M. Warnier, M.P. Merville, J. Gielen, J. Piette, V. Bours, and A. Chariot Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3 J. Biol. Chem. 278 2003 46541 46548
79. R.G. Vries, M. Prudenziati, C. Zwartjes, M. Verlaan, E. Kalkhoven, and A. Zantema A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300 EMBO J. 20 2001 6095 6103
80. J.H. Waterborg Steady-state levels of histone acetylation in Saccharomyces cerevisiae J. Biol. Chem. 275 2000 13007 13011
81. Y.L. Yao, W.M. Yang, and E. Seto Regulation of transcription factor YY1 by acetylation and deacetylation Mol. Cell. Biol. 21 2001 5979 5991
82. H. Zhong, M.J. May, E. Jimi, and S. Ghosh The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol. Cell 9 2002 625 636
83. Z. Zhu, W. Tang, A. Ray, Y. Wu, O. Einarsson, M.L. Landry, J. Gwaltney Jr., and J.A. Elias Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation J. Clin. Invest. 97 1996 421 430
84. J. Zlatanova, P. Caiafa, and K. Van Holde Linker histone binding and displacement: versatile mechanism for transcriptional regulation FASEB J. 14 2000 1697 1704